The active substance is inosine pranobex (complex containing inosine and 4 acetamidobenzoesan 2-hydroksypropylodimetyloamoniowy in a molar ratio of 1: 3). Each tablet contains 500 mg of inosine pranobeksu.
The other ingredients are:
wheat starch, mannitol, povidone, magnesium stearate.
The drug contains wheat starch. Drug should not be used patients with allergy (allergic) to wheat (other than celiac disease - known as celiac disease). The drug can be used Neosine patients with celiac disease.
The drug should be administered to persons with infections of the skin and mucous membranes caused by the presence of viruses: herpes variacella-zoster (chicken pox, shingles) and herpes simplex virus type I or type II (herpes simplex). Also recommended for other infections of viral origin and in the alternative case of a weakened immune system.
The preparation is in the form of tablets intended for oral use. It works on the basis of inosine pranobeksu responsible for the immunostimulatory and antiviral. The medicine is involved in the regulation of insufficient or incorrect mechanism of cellular immunity. This is done by causing Th1-type responses, resulting in the maturation and differentiation of lymphocytes grasicozależnych and intensifying induced lymphoproliferative response in cells stimulated with mitogen or antigen.
The preparation normalizes the mechanisms of cytotoxicity grasicozależnych lymphocytes and natural killer cells, lymphocyte function T8 suppressor and T4 helper. Moreover it contributes to increased levels of IgG and complement surface markers.
- Hypersensitivity to the active components of the preparation
- the current gout
- an increase in uric acid levels
Dosage Neosine Tablet
Oral use. In adults, it is recommended to use 50 mg / kg. (typically 1 g, ie. 2 tabl. x 3-4 / 24) does not receive a dose higher than 4 g / 24 h. In children over 1 year of age use 50 mg / kg. (usually 1 ml of syrup / kg. 3-4 times a day). Use the drug for 5-14 days.